Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robin Michelet

Showing results (41-50 of 74) with videos related to

Pageof 8
Sort By:
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 3, 2020
Quantification of microdialysis related variability in humans: Clinical trial design recommendationsDavid Busse, Philipp Simon, Robin Michelet, et al.
Frontiers in Pharmacology|January 30, 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approachRobin Michelet, Davide Bindellini, Johanna Melin, et al.
Clinical Pharmacokinetics|December 11, 2021
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese PatientsDavid Busse, Philipp Simon, Lisa Schmitt, et al.
Clinical Pharmacokinetics|October 4, 2022
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous InfusionYomna M Nassar, Nicolas Hohmann, Robin Michelet, et al.
Cancers|November 25, 2023
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling FrameworkYomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 8, 2024
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapyDavide Bindellini, Robin Michelet, Linda B S Aulin, et al.
Cancers|June 2, 2021
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical GroupsAnna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, et al.
Pharmaceuticals (Basel, Switzerland)|February 6, 2021
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing StrategiesAnna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, et al.
The AAPS Journal|July 26, 2015
Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 MaturationHuybrecht T'jollyn, Jan Snoeys, An Vermeulen, et al.
Clinical Pharmacokinetics|August 1, 2025
Author's Reply to Helsby and Hannam: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
Pageof 8

Showing results (41-50 of 74) with videos related to

Sort By:
Pageof 8
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|November 3, 2020
Quantification of microdialysis related variability in humans: Clinical trial design recommendationsDavid Busse, Philipp Simon, Robin Michelet, et al.
Frontiers in Pharmacology|January 30, 2023
Insights in the maturational processes influencing hydrocortisone pharmacokinetics in congenital adrenal hyperplasia patients using a middle-out approachRobin Michelet, Davide Bindellini, Johanna Melin, et al.
Clinical Pharmacokinetics|December 11, 2021
Comparative Plasma and Interstitial Tissue Fluid Pharmacokinetics of Meropenem Demonstrate the Need for Increasing Dose and Infusion Duration in Obese and Non-obese PatientsDavid Busse, Philipp Simon, Lisa Schmitt, et al.
Clinical Pharmacokinetics|October 4, 2022
Quantification of the Time Course of CYP3A Inhibition, Activation, and Induction Using a Population Pharmacokinetic Model of Microdosed Midazolam Continuous InfusionYomna M Nassar, Nicolas Hohmann, Robin Michelet, et al.
Cancers|November 25, 2023
C-Reactive Protein as an Early Predictor of Efficacy in Advanced Non-Small-Cell Lung Cancer Patients: A Tumor Dynamics-Biomarker Modeling FrameworkYomna M Nassar, Francis Williams Ojara, Alejandro Pérez-Pitarch, et al.
Journal of Pharmacokinetics and Pharmacodynamics|July 8, 2024
A quantitative modeling framework to understand the physiology of the hypothalamic-pituitary-adrenal axis and interaction with cortisol replacement therapyDavide Bindellini, Robin Michelet, Linda B S Aulin, et al.
Cancers|June 2, 2021
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical GroupsAnna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, et al.
Pharmaceuticals (Basel, Switzerland)|February 6, 2021
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing StrategiesAnna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, et al.
The AAPS Journal|July 26, 2015
Physiologically Based Pharmacokinetic Predictions of Tramadol Exposure Throughout Pediatric Life: an Analysis of the Different Clearance Contributors with Emphasis on CYP2D6 MaturationHuybrecht T'jollyn, Jan Snoeys, An Vermeulen, et al.
Clinical Pharmacokinetics|August 1, 2025
Author's Reply to Helsby and Hannam: 'Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights'Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
Pageof 8